CVA Family Office’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-66
Closed -$3.7K – 1308
2024
Q2
$3.7K Hold
66
– – ﹤0.01% 870
2024
Q1
$3.87K Hold
66
– – ﹤0.01% 861
2023
Q4
$3.56K Buy
+66
New +$3.22K ﹤0.01% 848
2023
Q3
– Sell
-66
Closed -$3.73K – 574
2023
Q2
$3.73K Hold
66
– – ﹤0.01% 837
2023
Q1
$3.56K Hold
66
– – ﹤0.01% 815
2022
Q4
$3.47K Hold
66
– – ﹤0.01% 772
2022
Q3
$3K Hold
66
– – ﹤0.01% 780
2022
Q2
$3K Hold
66
– – ﹤0.01% 796
2022
Q1
$4K Hold
66
– – ﹤0.01% 796
2021
Q4
$4K Buy
+66
New +$4.22K ﹤0.01% 777
2021
Q3
– Sell
-66
Closed -$4K – 595
2021
Q2
$4K Buy
+66
New +$3.82K ﹤0.01% 802

Other funds holding IHI

CVA Family Office's IHI Position: Q3 2024 in Review

CVA Family Office sold out of iShares US Medical Devices ETF (IHI) in Q3 2024, closing a stake of 66 shares — an estimated $3.7K sold.

CVA Family Office first reported a position in IHI in Q2 2021 and held it in 11 quarters. The position peaked at $4K in Q1 2022. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2024.

  • CVA Family Office reported no remaining iShares US Medical Devices ETF position as of Q3 2024 after selling out during the quarter.
  • CVA Family Office sold 66 iShares US Medical Devices ETF shares in Q3 2024, an estimated $3.7K.
  • CVA Family Office first reported a position in iShares US Medical Devices ETF in Q2 2021 and held it in 11 quarters.
  • CVA Family Office's iShares US Medical Devices ETF position peaked at $4K in Q1 2022.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2024.

Based on CVA Family Office's 13F filing for Q3 2024, filed 10 Oct 2024.